A new complementing cell line for replication-incompetent E1–deleted adenovirus propagation
- 18 November 2006
- journal article
- Published by Springer Nature in Cytotechnology
- Vol. 51 (3) , 133-140
- https://doi.org/10.1007/s10616-006-9023-6
Abstract
Recombinant adenoviruses (Ad) are being explored as promising delivery systems for gene therapy and vaccination. However, there is a concern about the possibility of generating replication-competent adenoviruses (RCA) using the human embryonic kidney 293 cell line. We have constructed a new cell line named the UR cell line which can be used to produce Ad vectors free of RCA. This cell line is based on the human embryonic lung HEL 299 cell. We first constructed a shuttle plasmid which encodes the E1A/E1B sequence that is necessary for adenovirus replication. The shuttle plasmid was then transfected into HEL 299 cells. The presence of the E1A/E1B sequence and protein expression in the stably transformed UR cells was confirmed. Viruses produced in UR cells were still RCA-free after ten test passages, while adenovirus produced in 293 cells had generated RCA during the fourth passage. We conclude that the UR cell line is sufficiently stable, can effectively produce a virus yield comparable with 293 cells, and does not generate RCA formation during Ad propagation.Keywords
This publication has 24 references indexed in Scilit:
- N-fragment of edema factor as a candidate antigen for immunization against anthraxVaccine, 2006
- Adenovirus-Based Genetic Vaccines for BiodefenseHuman Gene Therapy, 2005
- Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous VaccinesJournal of Virology, 2001
- Development of a packaging cell line for propagation of replication-deficient adenovirus vectorExperimental & Molecular Medicine, 2001
- Guidance for Human Somatic Cell Therapy and Gene TherapyHuman Gene Therapy, 2001
- Efficient Transformation of Primary Human Amniocytes by E1 Functions of Ad5: Generation of New Cell Lines for Adenoviral Vector ProductionHuman Gene Therapy, 2000
- A High-Efficiency Cre/loxP-Based System for Construction of Adenoviral VectorsHuman Gene Therapy, 1999
- Characterization of Replication-Competent Adenovirus Isolates from Large-Scale Production of a Recombinant Adenoviral VectorHuman Gene Therapy, 1999
- Recombinant Adenoviruses as VaccinesBiologicals, 1995
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977